iShares Russell 1000

The global eSports market is expected to reach $1 billion in 2017. Approximately one-third of the eSports fans in the United States participate in online amateur tournaments.

Best Buy (BBY) expects its revenue to keep falling in the first half of fiscal 2017, which ends on January 28, 2017, based on the current industry dynamics.

RAI’s increase in revenue was driven by the continued strong performance of Vuse Digital Vapor Cigarette in 4Q15.

Large caps will be in a much better position to navigate through this period given their cash positions.

In 2Q16, LyondellBasell’s (LYB) Olefins & Polyolefins – Europe, Asia, and International (or EAI) segment reported revenue of $2.7 billion.

Coca-Cola’s operating margin improved significantly to 15.2% in 4Q15 from 13.3% in the comparable quarter of the previous year.

National Oilwell Varco’s (NOV) net debt increased 4% in 1Q17 over 1Q16. Its net debt amounted to ~$1.7 billion in 1Q17.

Micron and Intel have developed 3D XPoint in a way that benefits from both DRAM (dynamic random access memory) and NAND (negative AND).

PepsiCo’s revenue in 2Q15 fell 5.7% due to a 10 percentage point impact of currency headwinds. PepsiCo expects currency headwinds to have an 11 percentage point impact on net revenue growth in 3Q15.

Alnylam Pharmaceuticals (ALNY) is currently developing three investigational therapies—Patisiran, Revusiran, and ALN-TTRsc02—for the treatment of patients with hereditary ATTR amyloidosis.

Coffee lovers in the United States are boosting ready-to-drink coffee volumes.

AbbVie (ABBV) plans to complete its Phase 3 registrational program for investigational next-generation Hepatitis C virus (or HCV) therapy by 2016.

Wedbush Securities analyst Dan Ives expects Tesla Model 3 demand to remain “very strong into 2019 and beyond.”

Boston Scientific (BSX) is consistently working towards gaining higher market share in the attractive TAVR (transcatheter aortic valve replacement) market in Europe.

JCPenney’s earnings were ahead of the consensus Wall Street analysts’ estimate of $0.21 per share.

As of January 28, 2016, PepsiCo (PEP) was trading at a forward price-to-earnings ratio of 20.6x.

Despite IBM’s Strategic Imperatives’ double-digit growth, IBM has been unable to post any revenue growth in the last 15 consecutive quarters. As a result, IBM’s stock touched a five-year low in late 2015.

National Oilwell Varco’s (NOV) total debt decreased ~18% in 4Q16 over 4Q15. Its cash and marketable securities decreased 31% during the same period.

Tesla has lost about 9.8% month-to-date as of December 27.

Atmel has a PE (price-to-equity) ratio of 80.3, which is way higher than Intel’s (INTC) 12.9, Texas Instrument’s (TXN) 18.19, and Microchip’s (MCHP) 26.9.

Biogen’s investigational Alzheimer’s disease drug, aducanumab, is one of the four therapies accepted in the EMA’s Priority Medicines program (or PRIME).

Schlumberger’s (SLB) net debt rose 65% in 1Q17—compared to 1Q16. Its net debt was ~$11.7 billion in 1Q17.

Baker Hughes’s (BHGE) North America segment saw 16.5% higher revenues from 2Q16 to 2Q17.

The ARMOURY stores will cater to the premium segment of the market. They’ll also feature UA product exclusives and occasional visits from star athletes.

In fiscal 2015, Fairchild’s cash from operating activities fell by 51% YoY to $94.4 million. That year, the company spent $96 million on share buybacks.

JCPenney (JCP) will be bringing a leading assortment of major appliances to 22 pilot stores effective February 1, 2016.

December is proving to be underwhelming for Tesla investors (IWB).

Sprint’s chief financial officer Tarek Robbiati discussed this second reason for the company’s 50% discount promotion.

In this part of the series, we’ll look at what Wall Street analysts recommend for Kinder Morgan (KMI).

Lowe’s (LOW) expects the Rona (RON.TO) transaction to be accretive to its earnings per share or EPS from the very first year after the acquisition.

Macy’s (M) has missed consensus Wall Street sales estimates in each of the first three quarters of fiscal 2015, which will end January 30, 2016.

Sprint’s revenues also declined 3% on a quarter-over-quarter basis by $255 million due to lower revenues in the equipment and wireless revenue segments.

National Oilwell Varco’s (NOV) management has identified demand growth in hydraulic fracturing equipment, closed-loop drilling, downhole tools, and completion tools.

VF Corporation (VFC) expects margins to improve in 2015, coming in at 49.3% compared to 48.8% in 2014. Margins have been expanding over the past few quarters.

For fiscal 3Q16, Qualcomm’s (QCOM) expects MSM shipments to be between 175 million–195 million units, the same guidance as reported for fiscal 2Q16.

When asked about a bear market, Gundlach took the opportunity to present some numbers. Currently, he’s in capital preservation mode.

After closing above its May 10 IPO listing price of $45 for the first time yesterday, Uber (UBER) was up 4% today. Can the rally last?

George Soros added 2.026 million shares of the SPDR Select Sector Fund (XLF) to its portfolio during the fourth quarter, giving it a weight of 1.5% in the portfolio.

Tesla (TSLA) has been one of the handful of positive-return-yielding stocks in the fourth quarter so far.

Musk seems to have found ways to retain power while meeting the SEC’s obligatory measures at the same time. Let’s take a closer look.

Before Tesla, many automakers launched limited-production electric models only to discontinue them soon after.

On December 26, 2017, 78% of the Wall Street analysts tracking Weatherford International rated it a “buy” or some equivalent.

In this article, we’ll look Wall Street’s call and target price for Weatherford International (WFT) on September 12.

Does National Oilwell management see a recovery in 2017? National Oilwell Varco (NOV) management identified strong US onshore activity and weak offshore energy exploration and production activity as the drivers behind its changing revenue mix in 2Q17. In the company’s 2Q17 conference call, chairman and CEO Clay C. Williams stated that “much of our business […]

Baker Hughes’s (BHGE) CFO (cash from operating activities) remained negative in 2Q17, continuing its negative cash flow trend in 1Q17.

National Oilwell Varco’s (NOV) management expressed concern over upstream energy companies’ lower capex spending, which is negative for the oilfield services companies.

In this article, we’ll look Wall Street analysts’ recommendations for Weatherford International (WFT) as of June 7, 2017.

Medtronic (MDT) reported ~$7.9 billion in worldwide revenues in fiscal 4Q17.

On May 9, 2017, Boston Scientific (BSX) announced the FDA approval of its Resonate family of products, including its ICD and CRT-D systems.

Let’s take a look at some of the projects that could affect National Oilwell Varco’s (NOV) returns going forward.

National Oilwell Varco’s (NOV) management expects upstream activity in North America’s shale plays to improve in 2017.

On March 1, ~71% of the analysts tracking Weatherford International rated it as a “buy,” ~20% rated it as a “hold,” and the rest rated it as a “sell.”

For fiscal 1Q17, AMAT expects its non-GAAP (generally accepted accounting principles) gross margin to rise 43.8% from 43.7% in fiscal 4Q16.

Unlike Biogen (BIIB) and Eli Lilly, who have focused their attention on amyloid-beta based therapeutics, AbbVie (ABBV) is reluctant to enter this field.

Together, AbbVie (ABBV) and Neurocrine Biosciences (NBIX) aim to develop Elagolix as a minimally invasive yet effective therapy for uterine fibroids

Of Medtronic’s ~$7.3 billion in worldwide revenues in fiscal 2Q17, ~$2.6 billion came from Medtronic’s CVG segment, representing ~35% of the company total.

On June 24, 2016, Pfizer (PFE) announced that it had completed the acquisition of Anacor Pharmaceuticals for a total net value of $5.2 billion. The acquisition added crisaborole.

On September 30, 2016, National Oilwell Varco’s (NOV) share price was 10% higher compared to December 31, 2015.

National Oilwell Varco’s (NOV) management expects most of the upstream recovery in North America to take place in 2H17.

National Oilwell Varco’s (NOV) net debt (total debt less cash & marketable securities) fell 20% in 3Q15.

Since January 2015, Amgen has traded at a premium to Gilead Sciences (GILD) but at a significant discount to peers Biogen (BIIB) and Celgene (CELG).

After the release of the FOMC’s November statement, Bill Gross said that monetary policy in the United States is steadily moving toward normalization, though its pace is slow.

In the first nine months of 2016, Amgen witnessed strong volume growth for its key products such as Xgeva, Prolia, Nplate, Vectibix, and Sensipar.

Medivation has added its robust research pipeline with two promising investigational drugs, Talazoparib and Pidilizumab, to Pfizer’s oncology portfolio.

On September 20, 2016, Medtronic posted its new safety and efficacy data for its Valiant Captivia Thoracic Stent Graft System.

Bristol-Myers Squibb’s and AbbVie’s multiple myeloma drug Empliciti, combined with Celgene’s Revlimid and dexamethasone, received approval from the FDA.

As of August 26, 2016, PPG Industries was trading at a one-year forward PE multiple of 16.0x compared to Sherwin-Williams and Valspar at 21.20x and 20.30x, respectively.

AbbVie (ABBV) expects to file a biologics license application for Rova-T as a third-line therapy for small cell lung cancer (or SCLC) in 2017.

TJX Companies anticipates its TJX Canada segment to deliver same-store sales growth of 7%–8% in fiscal 2017 and sales of $3.1 billion–$3.2 billion.

According to Richard Bernstein, the five charts in the recent edition of his newsletter are “five of our favorite charts that highlight what we think consensus is currently missing.”

Gilead Sciences reported diluted earnings per share (or EPS) of about $3.08 in 2Q16, which is a year-over-year (or YoY) decline of 2.2%.

As of July 22, 2016, Air Products and Chemicals (APD) was trading at a one-year forward PE multiple of 18.8x compared to its peers Praxair and FMC.

We could see fewer jobs added going forward. If this trend continues, bond (AGG) (BND) yields could most likely stay low.

A QE program doesn’t just create inflation; it causes asset prices to rise as well. After the financial crisis of 2008, the Fed resorted to an ultra-accommodative monetary policy.

Johnson & Johnson (JNJ) registered sales of approximately $6.4 billion in its Medical Devices business in 2Q16.

Estée Lauder (EL) ended calendar 1Q16 with a 3.5% rise in inventory.

A robust pipeline and strong R&D (research and development) capabilities are expected to drive significant revenue growth for JNJ’s Medical Devices segment.

As part of its restructuring initiative, Micron would only focus on critical projects and cut 2,400 jobs.

Amazon (AMZN), in order to keep its Prime membership popular, is offering two unlocked Android smartphones exclusively priced for Prime members.

Take-Two Interactive Software’s (TTWO) most successful franchise, Grand Theft Auto (or GTA), has sold over 235 million units worldwide.

Recently, Qualcomm launched an LTE (long-term evolution) modems for battery-powered IoT devices to increase their communication range.

In fiscal 1Q17, which ended on May 31, 2016, Constellation Brands’ gross margin increased significantly to 47.1% from 45.2% in fiscal 1Q16.

Medtronic’s (MDT) Restorative Therapies Group (or RTG) segment, formed around seven years ago, has a strong market position today.

Now in its phase-1 clinical trial, AbbVie’s PF-06647020, an ADC targeting protein kinase 7 could become a major therapy for advanced solid tumors.

IoT has a huge potential to create value for technology firms in the form of hardware, software, services, and integration.

During Cypress’s fiscal 1Q16 earnings call, CEO Thurman John Rodgers explained that Broadcom offloaded the wireless IoT segment for two reasons.

Analog Devices (ADI) has been using M&A (mergers and acquisitions) to rapidly expand its technology offerings and boost its revenue.

The company’s debt burden rose after it raised new debt to fund its $12 billion acquisition of Freescale. It also took on Freescale’s debt burden.

As Xilinx increases its share in the PLD market, a key will be its success in the long term is its competitive positioning compared to rival Altera.

A key semicond trend is likely to intensify as the automotive market progresses toward self-driving cars.

Texas Instruments (TXN) has increased its exposure in the automotive, industrial, and communications segments, which accounted for 64% of the company’s revenue in fiscal 1Q16.

Richard Bernstein spoke with CNBC’s Michael Santoli about what drives stock markets. He noted that his firm employs a top-down, macro research approach.

Boston Scientific’s (BSX) MedSurg segment contributes around 33% to the company’s total revenues and is the company’s second-largest segment.

Celgene has been working on its immunomodulatory backbone drugs to develop combination therapies for use in treating all lines of multiple myeloma.

With same-store sales growth being lowered, it is expected that Papa John’s (PZZA) EPS will also be revised downward.

On April 28, 2016, AbbVie (ABBV) announced its plans to acquire Stemcentrx. The deal is expected to be completed at a consideration of about $5.8 billion.

UnitedHealth Group’s healthcare delivery business, OptumHealth, managed to earn $4 billion revenues in 1Q16, which represents a YoY growth of about 22%.

In fiscal 1Q16, SanDisk’s (SNDK) revenue rose 3% YoY, topping analysts’ estimate and its own guidance. This was the first growth after four consecutive quarters of decline.

In fiscal 1Q16, Intel’s non-GAAP revenues rose by 8% YoY to $13.8 billion, missing the analyst estimate of $13.83 billion, which was a conservative one.

Although Intel (INTC) reported revenue growth across all major business segments, it missed the analyst revenue estimate by $30 million.